Compare

Avalo Therapeutics, Inc. vs Connect Biopharma Holdings Ltd vs HCW Biologics Inc. vs Actinium Pharmaceuticals, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearAvalo Therapeutics, Inc.
AVTX
Connect Biopharma Holdings Ltd
CNTB
HCW Biologics Inc.
HCWB
Actinium Pharmaceuticals, Inc.
ATNM
Year ended2025-12-312025-12-312025-12-312025-12-31
Revenue$59.0K$64.0K$54.2K$90.0K
Revenue growth (YoY)-86.6%-99.8%-97.9%n/a
Gross marginn/an/a20.0%n/a
Operating marginn/mn/mn/mn/m
Net marginn/mn/mn/mn/m
Net income-$78.26M-$55.48M-$7.96M-$33.89M
EPS (Diluted)-$5.84-$1.00-$10.63-$1.09
Operating cash flow-$51.46M-$51.21M-$13.39M-$24.58M
Free cash flown/a-$51.64M-$13.39M-$24.68M
Cash & equivalents$15.86M$38.34M$1.95M$48.00M
Total assets$116.46M$56.08M$24.52M$51.77M
Total liabilities$33.41M$14.10M$21.76M$43.94M
Shareholders' equity$83.05M$41.98M$2.76M$7.83M
Return on year-end equity-94.2%-132.2%-287.9%-432.6%
Shares outstanding18.51M56.44Mn/a31.20M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearAvalo Therapeutics, Inc.Connect Biopharma Holdings LtdHCW Biologics Inc.Actinium Pharmaceuticals, Inc.
Latest$59.0K
Ended 2025-12-31
$64.0K
Ended 2025-12-31
$54.2K
Ended 2025-12-31
$90.0K
Ended 2025-12-31
1 year earlier$441.0K
Ended 2024-12-31
$26.03M
Ended 2024-12-31
$2.57M
Ended 2024-12-31
n/a
2 years earlier$1.92M
Ended 2023-12-31
$0
Ended 2023-12-31
$2.84M
Ended 2023-12-31
$81.0K
Ended 2023-12-31
3 years earlier$18.05M
Ended 2022-12-31
n/a$6.72M
Ended 2022-12-31
$1.03M
Ended 2022-12-31
4 years earlier$5.40M
Ended 2021-12-31
n/a$0
Ended 2021-12-31
$1.14M
Ended 2021-12-31